Since myeloid leukaemia cells express the Kit receptor and are sensitive to SCF, this tyrosine kinase pathway has been suggested to contribute to leukaemia progression [1], [2], although, the molecular mechanisms of this pathophysiological SCF-Kit function remain unclear. This evidence concerns the gene KIT and myeloid leukemia.